Multiple sclerosis, infections and toxins Flashcards
Incidence of MS
30-80 per 100000 in Canada
Prevalence of MS in the world
depends on where you grew up and not where you live; more prevalent in countries with higher socioeconomic status and less prevalent in countries with warmer climates
Definition of MS
an autoimmune demyelinating (i.e. immune system attacks white matter) disease
Defining feature of MS
neurological episodes varying in time and space with a background of progressive decline
Groups vulnerable to MS
2-3x more common in females and 5x risk in those who have siblings with MS
Peak of onset and disability of MS
onset peaks in 30s-50s while disability peaks in 60s
Symptoms experienced during acute episodes in MS
focal weakness, paresthesias, monocular vision loss, diplopia, dysphagia, dysarthria, ataxia, bladder dysfunction
Chronic impairments in MS
fatigue, gait instability, focal spasticity, cognitive slowing, attention and memory problems, executive dysfunction
Paresthesias
tingling sensation caused by sensory change
Diplopia
double vision or seeing two images of a single object
Dysphagia
difficulty swallowing
Pathophysiology of MS
immunopathologic mechanism wherein lymphocytes and macrophages in immune system attack myelin on axons, forming new lesions along with old lesions in glial scar tissue
5 brain structures most affected in MS
cortex (periventricular), optic nerves, brainstem, spinal cord, cerebellum
How does epstein-barr virus cause MS?
increase in NfL, a protein found in blood and a biomarker of white matter damage, after EBV infection
2 ways to diagnose MS
detecting symptomatic lesions separated in time and space through MRI of brain and spinal cord; cerebrospinal fluid (spinal tap)